Efficacy of Brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients

BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) recipients are at risk for herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. Routine prophylaxis with acyclovir is recommended during periods of immunosuppression. Brincidofovir (BCV, CMX001), a lipid conjugate of cidof...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transpl Infect Dis
Main Authors: Lee, Yeon Joo, Neofytos, Dionysios, Kim, Seong Jin, Cheteyan, Leslie, Huang, Yao-Ting, Papadopoulos, Esperanza B., Jakubowski, Ann A., Papanicolaou, Genovefa A
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310478/
https://ncbi.nlm.nih.gov/pubmed/30120866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12977
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados